CN104547125A - Gastrointestinal drug and application thereof - Google Patents
Gastrointestinal drug and application thereof Download PDFInfo
- Publication number
- CN104547125A CN104547125A CN201410830441.4A CN201410830441A CN104547125A CN 104547125 A CN104547125 A CN 104547125A CN 201410830441 A CN201410830441 A CN 201410830441A CN 104547125 A CN104547125 A CN 104547125A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- gastrointestinal drug
- rhizoma
- gastrointestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a gastrointestinal drug. The gastrointestinal drug comprises the following raw materials in parts by weight: 135 to 165 parts of cuttlebone, 40 to 60 parts of fired corydalis tuber, 40 to 60 parts of radix astragali, 130 to 160 parts of chickens gizzard-membrane, 40 to 60 parts of prepared bighead atractylodes rhizome, 45 to 60 parts of agaric, 45 to 65 parts of dark plum, and 1 to 6 parts of rheum officinale, and further comprises 0 to 50 parts of galangal. The gastrointestinal drug is simple in formula, the drugs adopted are common easy to get, the gastrointestinal drug has no toxic or side effects during treatment, and meanwhile avoids decreased gastrointestinal immunity caused by long-term use of Western medicine, namely avoids medically so-called double infection.
Description
Technical field
The invention belongs to tcm field, be specifically related to a kind of gastrointestinal drug and the application in medicine thereof.
Background technology
Gastrointestinal disease is one of the most common clinically frequently-occurring disease, has the course of disease different in size, repeatedly the difficult feature healed.The kind of gastrointestinal disease is a lot, comprising: chronic enteritis, chronic gastritis (shallow, erosive, atrophic, reflux), gastric ulcer, duodenal ulcer, gastrorrhagia and result enteritis etc.The basic reason of gastroenteropathy is that the Mycoderma barrier of human body probiotics composition suffers to destroy, the toxin of harmful bacteria and secretion thereof corrodes gastrointestinal mucosa.Conventional medicament while killing the intestines and stomach harmful bacteria, the probiotics that also to have killed the intestines and stomach next required.Although relief of symptoms, eliminate inflammation, the minimizing of probiotics makes the intestines and stomach immunity reduce, and the easy subinfection again of an amount drug withdrawal, is medically called " superinfection ", progressively develops into chronic gastroenteropathy.But with regard to treatment by Chinese herbs, go because it is eliminating evil because of, strengthening the body resistance, coordination zang-fu differentiation function, thus can correct and yin or yang excessly partially to decline, make body recovery arrive the normal condition of YIN and YANG in a relative equilibrium, therefore, a kind of Chinese medicine formula can treating gastrointestinal disease is provided to seem very important.But current each Chinese medicine formula medicine is expensive, or formula is complicated, takes inconvenience, or specific aim is too strong, can not play the effect for the treatment of to general disease.
Summary of the invention
An object of the present invention is for providing a kind of medicine for the treatment of gastrointestinal disease, this medicine can treat gastritis, ulcer, distending pain, dyspepsia, digestive tract power is not enough, the disease of enteritis, and have no side effect, avoid the intestines and stomach immunity reduction that long-term taking Western medicine causes, namely avoid medically alleged " superinfection ".
A kind of gastrointestinal drug, comprises the raw material of following weight: Os Sepiae 135 ~ 165 parts, Rhizoma Corydalis processed 40 ~ 60 parts, Huang Shi 40 ~ 60 parts, Endothelium Corneum Gigeriae Galli 130 ~ 160 parts, system states 40 ~ 60 parts, Polyporus 45 ~ 60 parts in vain, Fructus Mume 45 ~ 65 parts, Radix Et Rhizoma Rhei 1 ~ 6 part, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
Preferably, a kind of gastrointestinal drug, comprises the raw material of following weight: Os Sepiae 140 ~ 160 parts, Rhizoma Corydalis processed 40 ~ 55 parts, Huang Shi 45 ~ 60 parts, Endothelium Corneum Gigeriae Galli 140 ~ 160 parts, system states 40 ~ 50 parts, Polyporus 45 ~ 55 parts in vain, Fructus Mume 45 ~ 60 parts, Radix Et Rhizoma Rhei 2 ~ 5 parts, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
Preferably, a kind of gastrointestinal drug, comprises the raw material of following weight: Os Sepiae 140 ~ 150 parts, Rhizoma Corydalis processed 40 ~ 50 parts, Huang Shi 45 ~ 50 parts, Endothelium Corneum Gigeriae Galli 145 ~ 150 parts, system states 45 ~ 50 parts, Polyporus 45 ~ 50 parts in vain, Fructus Mume 50 ~ 60 parts, Radix Et Rhizoma Rhei 3 ~ 5 parts, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
Preferably, a kind of gastrointestinal drug, comprises the raw material of following weight: Os Sepiae 150 parts, Rhizoma Corydalis processed 50 parts, Huang Shi 50 parts, Endothelium Corneum Gigeriae Galli 150 parts, and system states 50 parts, Polyporus 50 parts, Fructus Mume 50 parts, Radix Et Rhizoma Rhei 5 parts in vain, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
Further, gastrointestinal drug can make powder, pill, tablet, capsule, oral liquid or Chinese medicine decoction.
Further, the application in the medicine of gastrointestinal drug one or more diseases below preparation treatment, described disease is: gastritis, ulcer, distending pain, dyspepsia, digestive tract power are not enough, enteritis.
Further, in medicine, the addition of Rhizoma Alpiniae Officinarum can be added according to the order of severity of cold syndrome of the stomach symptom in patient condition, and system states in vain and Rhizoma Corydalis processed all adopts traditional method to process.
Beneficial effect of the present invention is: pharmaceutical formulation provided by the invention is simple, medicine used is common to be easy to get, treat in the process of above-mentioned disease and have no side effect, avoid the intestines and stomach immunity reduction that long-term taking Western medicine causes simultaneously, namely avoid medically alleged " superinfection ".
Detailed description of the invention
Hereafter will describe content of the present invention in conjunction with specific embodiments in detail.It should be noted that the combination of technical characteristic or the technical characteristic described in following embodiment should not be considered to isolated, they can mutually be combined thus be reached better technique effect.
Embodiment 1
Raw material by following weight in grams proportioning: Os Sepiae 150 grams; Rhizoma Corydalis processed 50 grams, Huang Shi 50 grams, Endothelium Corneum Gigeriae Galli 150 grams; system states 50 grams in vain; Polyporus 50 grams, Fructus Mume 50 grams, Radix Et Rhizoma Rhei 5 grams breaks into powdery mix homogeneously; then add 3000ml water to heat; be replaced by slow fire after boiling and boil one hour, after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 2
Raw material by following weight in grams proportioning: Os Sepiae 135 grams; Rhizoma Corydalis processed 40 grams, Huang Shi 40 grams, Endothelium Corneum Gigeriae Galli 130 grams; system states 40 grams in vain; Polyporus 45 grams, Fructus Mume 45 grams, Radix Et Rhizoma Rhei 1 gram breaks into powdery mix homogeneously; then add 3000ml water to heat; be replaced by slow fire after boiling and boil one hour, after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 3
Raw material by following weight in grams proportioning: Os Sepiae 165 grams; Rhizoma Corydalis processed 60 grams, Huang Shi 60 grams, Endothelium Corneum Gigeriae Galli 160 grams; system states 60 grams in vain; Polyporus 60 grams, Fructus Mume 65 grams, Radix Et Rhizoma Rhei 2 grams breaks into powdery mix homogeneously; then add 3500ml water to heat; be replaced by slow fire after boiling and boil one hour, after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 4
Raw material by following weight in grams proportioning: Os Sepiae 140 grams; Rhizoma Corydalis processed 40 grams, Huang Shi 45 grams, Endothelium Corneum Gigeriae Galli 140 grams; system states 50 grams in vain; Polyporus 45 grams, Fructus Mume 45 grams, Radix Et Rhizoma Rhei 3 grams breaks into powdery mix homogeneously; then add 3000ml water to heat; be replaced by slow fire after boiling and boil one hour, after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 5
Raw material by following weight in grams proportioning: Os Sepiae 150 grams; Rhizoma Corydalis processed 40 grams, Huang Shi 45 grams, Endothelium Corneum Gigeriae Galli 145 grams; system states 50 grams in vain; Polyporus 45 grams, Fructus Mume 50 grams, Radix Et Rhizoma Rhei 4 grams breaks into powdery mix homogeneously; then add 3000ml water to heat; be replaced by slow fire after boiling and boil one hour, after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 6
Raw material by following weight in grams proportioning: Os Sepiae 160 grams, Rhizoma Corydalis processed 55 grams, Huang Shi 55 grams; Endothelium Corneum Gigeriae Galli 155 grams; system states 45 grams, Polyporus 44 grams, Fructus Mume 55 grams in vain; Radix Et Rhizoma Rhei 5 grams breaks into powdery mix homogeneously; then add 3000ml water to heat, after boiling, add Rhizoma Alpiniae Officinarum 10 grams, be replaced by slow fire and boil one hour; after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 7
Raw material by following weight in grams proportioning: Os Sepiae 155 grams, Rhizoma Corydalis processed 55 grams, Huang Shi 50 grams; Endothelium Corneum Gigeriae Galli 155 grams; system states 55 grams, Polyporus 52 grams, Fructus Mume 48 grams in vain; Radix Et Rhizoma Rhei 4 grams breaks into powdery mix homogeneously; then add 3000ml water to heat, after boiling, add Rhizoma Alpiniae Officinarum 20 grams, be replaced by slow fire and boil one hour; after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 8
Raw material by following weight in grams proportioning: Os Sepiae 147 grams, Rhizoma Corydalis processed 46 grams, Huang Shi 53 grams; Endothelium Corneum Gigeriae Galli 148 grams; system states 55 grams, Polyporus 47 grams, Fructus Mume 48 grams in vain; Radix Et Rhizoma Rhei 5 grams breaks into powdery mix homogeneously; then add 3000ml water to heat, after boiling, add Rhizoma Alpiniae Officinarum 30 grams, be replaced by slow fire and boil one hour; after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 9
Raw material by following weight in grams proportioning: Os Sepiae 154 grams, Rhizoma Corydalis processed 57 grams, Huang Shi 51 grams; Endothelium Corneum Gigeriae Galli 140 grams; system states 47 grams, Polyporus 52 grams, Fructus Mume 48 grams in vain; Radix Et Rhizoma Rhei 4 grams breaks into powdery mix homogeneously; then add 3000ml water to heat, after boiling, add Rhizoma Alpiniae Officinarum 40 grams, be replaced by slow fire and boil one hour; after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
Embodiment 10
Raw material by following weight in grams proportioning: Os Sepiae 149 grams, Rhizoma Corydalis processed 51 grams, Huang Shi 52 grams; Endothelium Corneum Gigeriae Galli 148 grams; readme processed 47 grams, Polyporus 53 grams, Fructus Mume 52 grams; Radix Et Rhizoma Rhei 5 grams breaks into powdery mix homogeneously; then add 3000ml water to heat, after boiling, add Rhizoma Alpiniae Officinarum 50 grams, be replaced by slow fire and boil one hour; after ceasing fire, cooling, then filters to get filtrate.Patient takes gained filtrate 30ml every day in half an hour ante cibum, adheres to taking seven days.
In embodiment, after also medicine can being cleaned pulverize, boiled water is taken after mixing it with water, or adds common drug auxiliary additive and be pressed into tablet or capsule.Patient takes rear cure rate and reaches 98%.
Although give some embodiments of the present invention, it will be understood by those of skill in the art that without departing from the spirit of the invention herein, can change embodiment herein.Above-described embodiment is exemplary, should using embodiment herein as the restriction of interest field of the present invention.
Claims (5)
1. a gastrointestinal drug, it is characterized in that, comprise the raw material of following weight: Os Sepiae 135 ~ 165 parts, Rhizoma Corydalis processed 40 ~ 60 parts, Huang Shi 40 ~ 60 parts, Endothelium Corneum Gigeriae Galli 130 ~ 160 parts, system states 40 ~ 60 parts, Polyporus 45 ~ 60 parts, Fructus Mume 45 ~ 65 parts in vain, Radix Et Rhizoma Rhei 1 ~ 6 part, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
2. a kind of gastrointestinal drug as claimed in claim 1, it is characterized in that, described gastrointestinal drug comprises the raw material of following weight: Os Sepiae 140 ~ 160 parts, Rhizoma Corydalis processed 40 ~ 55 parts, Huang Shi 45 ~ 60 parts, Endothelium Corneum Gigeriae Galli 140 ~ 160 parts, system states 40 ~ 50 parts, Polyporus 45 ~ 55 parts, Fructus Mume 45 ~ 60 parts in vain, Radix Et Rhizoma Rhei 2 ~ 5 parts, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
3. a kind of gastrointestinal drug as claimed in claim 1, it is characterized in that, described gastrointestinal drug comprises the raw material of following weight: Os Sepiae 140 ~ 150 parts, Rhizoma Corydalis processed 40 ~ 50 parts, Huang Shi 45 ~ 50 parts, Endothelium Corneum Gigeriae Galli 145 ~ 150 parts, system states 45 ~ 50 parts, Polyporus 45 ~ 50 parts, Fructus Mume 50 ~ 60 parts in vain, Radix Et Rhizoma Rhei 3 ~ 5 parts, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
4. a kind of gastrointestinal drug as claimed in claim 1, is characterized in that, described gastrointestinal drug comprises the raw material of following weight: Os Sepiae 150 parts, Rhizoma Corydalis processed 50 parts, Huang Shi 50 parts, Endothelium Corneum Gigeriae Galli 150 parts, system states 50 parts, Polyporus 50 parts in vain, Fructus Mume 50 parts, Radix Et Rhizoma Rhei 5 parts, also comprises Rhizoma Alpiniae Officinarum 0 ~ 50 part.
5. a kind of gastrointestinal drug as described in any one of Claims 1-4, is characterized in that, described gastrointestinal drug can make powder, pill, tablet, capsule, oral liquid or Chinese medicine decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410830441.4A CN104547125A (en) | 2014-12-29 | 2014-12-29 | Gastrointestinal drug and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410830441.4A CN104547125A (en) | 2014-12-29 | 2014-12-29 | Gastrointestinal drug and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104547125A true CN104547125A (en) | 2015-04-29 |
Family
ID=53064896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410830441.4A Pending CN104547125A (en) | 2014-12-29 | 2014-12-29 | Gastrointestinal drug and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547125A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998185A (en) * | 2015-08-17 | 2015-10-28 | 王德存 | Traditional Chinese medicine composition for treating gastrointestinal disease |
| CN106377720A (en) * | 2016-11-21 | 2017-02-08 | 黄易业 | Stomach medicine and preparation method thereof |
-
2014
- 2014-12-29 CN CN201410830441.4A patent/CN104547125A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998185A (en) * | 2015-08-17 | 2015-10-28 | 王德存 | Traditional Chinese medicine composition for treating gastrointestinal disease |
| CN106377720A (en) * | 2016-11-21 | 2017-02-08 | 黄易业 | Stomach medicine and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110548077A (en) | Pharmaceutical composition for treating chronic pharyngitis and preparation method and application thereof | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN104547125A (en) | Gastrointestinal drug and application thereof | |
| CN104042713B (en) | A kind of Chinese medicine composition for the treatment of bronchial asthma | |
| CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
| CN103006893A (en) | Medicine for treating chronic rhinitis and preparation method thereof | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN102091138B (en) | Gastrointestinal tablet and preparation process thereof | |
| CN103751673A (en) | Tibetan medicinal composition for treating diarrhea of yak calf | |
| CN103405745A (en) | Traditional Chinese medicine composition for treating canine gastroenteritis | |
| CN104208577B (en) | Treat the medicine of gastric ulcer | |
| CN102755419A (en) | Chinese and Western medicine compound preparation for treating chronic gastritis and peptic ulcer | |
| CN103479948B (en) | The anti-medicine treated constipation | |
| CN102641413A (en) | Medicine for treating acute enteritis and preparing method thereof | |
| CN102266537B (en) | Chinese prepared medicine for treating chronic gastritis and gastroduodenal ulcer and preparation method thereof | |
| CN106860646B (en) | Traditional Chinese medicine composition for treating gastroduodenal ulcer and preparation method thereof | |
| CN101670046A (en) | Chinese medicinal composition for gastritis and esophagitis and preparation process thereof | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN105012851A (en) | Traditional Chinese medicine composition for treating uremia | |
| CN105396107A (en) | Traditional Chinese medicine composition for curing gastroenteritis | |
| CN105287798A (en) | Lipid-lowering and slimming recovery pill | |
| CN105213927A (en) | A kind of medicine for the treatment of acute enteritis and preparation method thereof | |
| CN104274512A (en) | Traditional Chinese medicine for treatment of chronic atrophic gastritis | |
| CN104337958A (en) | Medicament for treating emphysema and preparation method thereof | |
| CN105561115A (en) | Traditional Chinese medicinal composition for treating uremia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |